[Clinical trial of daunomycin in gynecological oncology].
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008175:Lung Neoplasms; D009217:Myosarcoma / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D000637:Transaminases / Q000097:blood; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D010744:Phosphoric Monoester Hydrolases; D003630:Daunorubicin
Sperimentazione clinica della daunomicina in oncologia ginecologica.